Cord blood (CB) is an alternative source of marrow repopulating cells for the treatment of pediatric patients. Over the past 7 years, the results of CB transplantation for pediatric Assuming a threshold of 2 × 10 7 nucleated cells (NC)/kg body weight required for transplantation and 10 ± 5 × 10 8 diseases have been promising. Over 500 unrelated and related cord blood transplants have been performed. + CB cells were cultured with the four cytokine combinations in H5100 medium, all combi-10 ± 5 × 10 8 nucleated cells (NC) stored in the CB Bank Düsseldorf, 100%, 65% and 25% contain sufficient NC to nations promoted an expansion of total cells (43 to 356-fold) and CFC (49 to 462-fold) within 7 days, however, engraft patients of 10 kg, 35 kg and 50-70 kg, respectively, when a threshold of 2 × 10 7 NC/kg body weight required early progenitors as defined by mixed-colony formation (CFU-GEMM) were substantially amplified only with for transplantation is assumed. Therefore, ex vivo expansion of stem/progenitor cells from human cord blood prior to SCF, Flt3-L plus IL-3 (94.3 ± 62.4-fold). H5100 medium or a serum-free medium supplemented with SCF, Flt3-L transplantation would be an attractive approach to obtain the quantity and quality of CB cells required for successful plus IL-3 were superior to 20% FCS/RPMI-1640 medium in the expansion of all progenitor cell types and were simi-(ie rapid, complete and sustained) long-term hematopoietic reconstitution after transplantation in adults.
important when expanded cells are to be used in CB transEx vivo expansion of CD34 + enriched progenitor cells from frozen CB plantation.
In the present study, CD34 + cells isolated from fresh or For expansion, CD34
+ enriched CB cells (1 × 10 3 / cryopreserved CB samples (thawed according to a clinical 100 l/well) were plated in a liquid culture system in protocol) were studied, firstly, to select the most efficient H5100 medium (StemCell Technologies, Vancouver, combination of growth factors and secondly, to define the Canada) in 96-well plates (Greiner, Nürtingen, Germany). medium conditions and kinetics for a short-term ex vivo
The following cytokine combinations were added twice a expansion of distinct hematopoietic compartments (ie LTCweek and half of the medium was replaced once a week: IC, CFC including CFU-GEMM, CFU-GM and BFUMix 1: 100 ng/ml hu-Flt3-L (Genzyme, Rüsselsheim, Ger-E/CFU-E). The results presented in this study may have many or kindly provided by Dr S Lyman, Immunex, important implications for the use of expanded CB cells as Seattle, WA, USA) and 100 ng/ml hu-SCF (specific activity a source of hematopoietic cells for marrow replacement.
1 × 10 5 U/mg, Immunex); Mix 2: 100 ng/ml Flt3-L, 100 ng/ml SCF and 20 ng/ml hu-IL3 (specific activity 2 × 10 7 U/mg, Immunex); Mix 3: 100 ng/ml Flt3-L, Materials and methods 100 ng/ml SCF, 20 ng/ml IL-3 and 2 U/ml hu-erythropoietin (Epo; Boehringer-Mannheim, Mannheim, Germany); Mix 4: 100 ng/ml Flt3-L, 100 ng/ml SCF, 20 ng/ml IL-3, Collection of CB 2 U/ml Epo and 200 U/ml hu-GM-CSF (specific activity Collection of CB in the Obstetric Departments was perfor-1.25 × 10 7 U/mg, Immunex). The cultures were incubated med with informed consent of the mother. After delivery at 37°C and 5% CO 2 in a fully humidified atmosphere. Cell of the baby with the placenta still in utero, the umbilical counts and colony-forming assays were performed from the cord was doubly clamped and transected 7-10 cm away expanding cell cultures at days 0, 7, 14 and 21. from the umbilicus. After disinfection of the cord, the umbilical vein was punctured and CB collected into 150 (1 × 10 3 /well) were plated in a liquid culture system in 100 l H5100 medium, serum-free medium (kindly proUnseparated CB samples were resuspended vol/vol in icevided by Drs A Migliaccio and G Migliaccio, Laboratorio cold freezing medium (70% RPMI-1640 without phenol di Biologia Cellulare, Istituto Superiore di Sanitá, Rome, red) (ICN, Costa Mesa, CA, USA), 20% dimethylsulfoxide Italy) or RPMI-1640 medium with 20% FCS. Cell counts, (Sigma-Aldrich, Irvine, UK) and 10% human serum albucolony-forming assays and LTC-IC assays were performed min (Behring, Marburg, Germany) and frozen as from the expanding cell cultures at days 0, 7, 14 and 21. described previously.
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Thawing of CB units was performed as described by
Human progenitor colony-forming assay Rubinstein et al. 24 Briefly, CB bags were placed in the gas phase of liquid nitrogen for 30 min and then exposed to Hematopoietic progenitor cell assays were performed in a room temperature for 5 min. The bags were thawed in a ready-to-use granulocyte-erythroid-macrophage-megakar-37°C water bath as rapidly as possible. Immediately after yocyte colony-forming unit (CFU-GEMM) semi-solid thawing, each CB unit was diluted with an equal volume medium, containing 0.3% methylcellulose, 5 U/ml hu-IL-3, of a solution containing 5% human serum albumin 30 U/ml hu-IL-6, 10 U/ml hu-G-CSF, 3 U/ml hu-Epo and (Behring) and 10% Dextran 40 (Delta Pharma, Pfullingen, 15 ng/ml hu-SCF (StemBio Research, Villejuif, France). Germany) in 0.9% NaCl, and subsequently sedimented at Cells were seeded in triplicate cultures in 24-well cell cul-250 g for 10 min. The supernatant was removed and sediture plates (Costar, Cambridge, MA, USA). Because of the mented cells resuspended slowly in fresh albumin/dextran high variability of progenitor cells in the various fractions, solution. Alternatively, samples were thawed with 50% the total number of cells seeded was adjusted for each cell FCS/RPMI-1640 as described previously. 
MACS enrichment resulted in a CD34
+ purity of 74-88% cells/l CB based on the determination of CB nucleated (Table 1) . Thawing with an albumin/dextran solution not cells with the extended lysis protocol on a CellDyn 3500 only revealed a significantly higher yield of CD34 + cells analyzer (Abbot, Wiesbaden, Germany).
(P = 0.014) but also a higher yield of CFC (P Ͻ 0.01) and LTC-IC (P Ͻ 0.01) in comparison to thawing with 50% FCS/RPMI-1640.
Long-term culture-initiating cell assay

LTC-IC assays were performed according to a technique
The effect of different growth factor combinations on the previously described by Sutherland et al. 27 Briefly, mono-7-day expansion of CD34 + CB cells nuclear cells from healthy volunteer bone marrow donors were seeded in 25 cm 2 tissue culture flasks (Greiner) at To determine an optimal growth factor combination for the 2 × 10 6 /ml in RPMI-1640 supplemented with 12.5% fetal ex vivo expansion of thawed CB CD34 + cells (purity calf serum (FCS; Gibco/Life Technologies, Eggenstein, 85 ± 15%), different growth factor combinations (Mix 1: Germany), 12.5% horse serum (Sigma, St Louis, MO, Flt3-L, SCF; Mix 2: Flt3-L, SCF, IL-3; Mix 3: Flt3-L, SCF, USA) and 10 −6 M hydrocortisone sodium succinate (Sigma). IL-3, Epo; Mix 4: Flt3-L, SCF, IL-3, Epo, GM-CSF) were After 2 to 3 weeks, the adherent cells were harvested and compared regarding their expansion potential for total cells irradiated (15 Gy). After irradiation, the adherent cells and CFC after 7 days in liquid culture in H5100 medium (1 × 10 5 /ml/well) were replated in 24-well plates and cul- (Table 2) . In five experiments, all four cytokine combitured in the medium described above. Three days later, the nations induced an increase in the total number of cells, stromal layers were recharged with CD34
+ cells (5 × 10 3 ) ranging from 43-fold (Mix 1) to 356-fold (Mix 4). Despite or expanded cells (1 × 10 4 ). In addition, the genetically an expansion of total CFC with all four growth factor comengineered cell lines M2-10B4 and S1/S1 (kindly provided binations ranging from 49-fold (Mix 1) to 462-fold (Mix 3), by Dr DE Hogge, Terry Fox Laboratory, Vancouver, the individual CFC types were amplified differently. Thus, Canada), producing IL-3 and G-CSF and IL-3 and SCF, the addition of Epo and GM-CSF to SCF + Flt3-L + IL-3 respectively, were used as feeder layer as described preincreased the number of CFC (442 ± 320-fold vs 166 ± 75-viously. 28 The cultures were incubated for 6 weeks and fed fold). However, the majority of CFC (Figure 1 ) consisted weekly by removing half of the medium without cells and of more differentiated BFU-E/CFU-E and CFU-GM. In adding an equal volume of fresh medium. After 6 weeks contrast, CFU-GEMM were only poorly amplified with of culture, the adherent and non-adherent cells were harMix 4 (1 ± 3-fold) compared to the 94 ± 62-fold amplifivested and evaluated in a density of 1 × 10 5 cells/ml for cation with Mix 2 (P = 0.022) and even the higher cellular CFU-GM, BFU-E and CFU-GEMM as described above. 
CFC (%) LTC-IC (%)
of ex vivo expansion were compared using the Student's t-
test. Probability (P) values of less than 0.05 were considered statistically significant.
Fresh CB (n = 13) 84 ± 13 78 ± 11 70 ± 11 52 ± 17 (n = 8) Cryopreserved CB Thawing with FCS/ 74 ± 8 50±13 51 ± 9 3 4±9 
expansion was calculated based on the cell counts (1000), CFC (38.6 ± 5.5), BFU/CFU-E (25.8 ± 7.9), CFU-GM (11.4 ± 2.3) and CFU-GEMM (1.4 ± 0.5) on day 0. occurred within the first 7 days of tissue culture with all four cytokine combinations. GFU-GEMM were only substantially amplified with Flt3-L, SCF plus IL-3 after 7 days.
Flt3-L and SCF alone (Figure 2a ) resulted in only a 49 ± 27-fold maximal amplification of CFC after 7 days, although GFU-GEMM were amplified 55 ± 18-fold.
In the presence of Flt3-L, SCF and IL-3 (Figure 2b ), the total cell count increased over the 21-day culture period and following 21 days of tissue culture, a 451 ± 177-fold expansion was observed. CFC amplification (168 ± 30-fold) including amplification of BFU-E/CFU-E (207 ± 60-fold) and CFU-GM (264 ± 212-fold) was maximal following 7-14 days of tissue culture but declined thereafter. An increase in CFU-GEMM (94 ± 62-fold) was only observed at day 7, CFU-GEMM were not detectable at later time points.
The addition of Epo to Flt3-L, SCF and IL-3 (Figure 2c BFU-E/CFU-E. Low numbers of CFU-GEMM were obtained after 7 days (1 ± 3-fold) but not detectable at 14 and 21 days. yield in the presence of Mix 4 did not result in higher absolute CFU-GEMM numbers compared to Mix 2. Thus, Mix 2 was superior to the other cytokine combinations in the Kinetics of the ex vivo expansion of CD34 + CB cells in expansion of less differentiated/committed progenitor cells the presence of Flt3-L, SCF and IL3 under different but also allowed a substantial amplification of BFU-E and medium conditions over 21 days CFU-GM, whereas Mix 4 predominantly caused an amplification of more differentiated progenitor cells after 7 days
In a second set of experiments, based on the data obtained from the experiments described above, different media of tissue culture.
(H5100, serum-free medium and 20% FCS/RPMI-1640 medium) were tested for their ability to expand clonogenic
Kinetics of the ex vivo expansion of CD34 + CB cells with cells and LTC-IC in 21-day liquid cultures of CD34 + cells the four growth factor combinations over 21 days
in the presence of Flt3-L, SCF and IL-3 ( Figure 3 and Table 3 ). For all three media, the total number of cells Next, the kinetics of expansion of CD34 + cells over 21 days was studied (Figure 2a-d) . The maximum increase in the increased over the 21-day culture period reaching a maximal amplification at 21 days (Figure 3a) , which was total number of cells, CFU, BFU-E/CFU-E and CFU-GM 410 ± 131-fold, 335 ± 105-fold and 72.5 ± 14-fold for serum-free medium (P = 0.0203) already at day 7. Similarly, production of CFU-GM (Figure 3d and Table 3 ) was H5100, serum-free and FCS medium, respectively. Flt3-L, SCF and IL-3 in the presence of H5100 or serum-free comparable for H5100 or serum-free medium, whereas in the presence of FCS/RPMI-1640, the production was sigmedium resulted in the highest CFC expansion at day 14 (234 ± 181-fold and 244 ± 83-fold, Figure 3b ). In the presnificantly reduced at day 7 (P = 0.0215 and P = 0.0283, respectively). The same was observed for the BFU-E/CFUence of 20% FCS/RPMI-1640, the number of CFC was significantly lower in comparison to H5100 (P = 0.0155) or E output (Table 3) . Table 3 The effects of different media on the fold expansion of CD34 + CB cells after 7 days in the presence of Flt3-L, SCF plus IL-3
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Total cells CFC BFU/ CFU-GM CFU-GEMM LTC-IC CFU-E
(1) H5100
151.3 ± 88.9 170.7 ± 64.7 136.6 ± 39.5 237.1 ± 137.9 83.5 ± 26.2 6.7 ± 3.4 (2) Serum-free 112.0 ± 56.9 174.2 ± 62.8 119.6 ± 27.8 266.1 ± 150.4 176.9 ± 81.7 5.5 ± 0.5 (3) FCS/RPMI-1640 8.7 ± 0.7 54.3 ± 18.9 70.0 ± 25.5 8. 
. purity: 88 ± 13%) were cultured in the presence of H5100, serum-free or 20% FCS/RPMI-1640 medium supplemented with Ftl3-L, SCF plus IL-3. Cell, CFC and LTC-IC counts were determined after 7 days. Fold amplification was calculated based on the cell counts (1000), CFC (42.3 ± 8.0), BFU/CFU-E (25.0 ± 6.9), CFU-GM (15.5 ± 6.1), CFU-GEMM (1.8 ± 0.8) and LTC-IC (8.1 ± 3.9) on day 0 for H5100 and serum-free medium. For FCS/RPMI-1640 medium, the values on day 0 were as follows: cell count, 40 000; CFC, 455 ± 87; BFU/CFU-E, 332 ± 54.6; CFU-GM, 111 ± 28.3; CFU-GEMM, 2.1 ± 4 and LTC-IC, 50 ± 4.
The kinetics of the CFU-GEMM expansion (Figure 3e) ber of cycling LTC-IC in blood and bone marrow can be stimulated by simple cytokine cocktails. over 21 days showed the largest differences between the media. CFU-GEMM expansion was significantly higher
At the present time, the ability to expand primitive hematopoietic stem and progenitor cells from CB is of major under serum-free conditions at day 7 (176.9 ± 81.7-fold) than in the presence of H5100 medium (83.5 ± 26.2 fold;
interest. Therefore, in this study, several different factors which affect the expansion of CD34-enriched CB cells P = 0.0183) or FCS/RPMI-1640 (P Ͻ 0.01). In addition, only the serum-free medium was able to partially maintain were analyzed in an effort to define short-term culture conditions that induce an expansion of cells and CFC, while the capacity to produce CFU-GEMM over 21 days (Figure 3e) . maintaining or expanding LTC-IC: (1) the thawing method prior to enrichment of CD34 + cells; (2) the growth factor As shown in Figure 3f and Table 3 , the combination of Flt3-L, SCF and IL-3 in H5100 and serum-free medium combination; and (3) the medium conditions. Thawing of the cryopreserved CB unit according to the promoted a 6.7 ± 3.4-fold and 5.5 ± 0.5-fold amplification of LTC-IC at day 7, respectively. LTC-IC numbers were protocol of Rubinstein et al 24 prior to CD34 + selection with the MACS system (Table 1) significantly enhanced the significantly less in the FCS/RPMI-1640 containing medium (2.1 ± 0.7-fold; P = 0.024). However, all three culyield of CD34 + cells, CFC and of LTC-IC compared to thawing in 50% FCS/RPMI-1640. Thus, by employing an ture conditions failed to expand or maintain LTC-IC over longer periods. efficient thawing procedure, the need for ex vivo expansion first to have to compensate for cell losses during thawing can be avoided. Growth factor combinations containing Flt3-L that had Discussion previously been documented as efficient for the enhanced expansion of immature subsets of CD34 + separated CB Early calculations suggested that there might be enough hematopoietic progenitor and stem cells in an average CB cells 17 were examined in the context of optimal CFU-GM and CFU-GEMM expansion over 7 days (short-term sample to reconstitute adult patients, but the ability to engraft an adult may require growth factor mediated expanculture). Flt3-L, SCF and IL-3 were found to be an efficient combination for the expansion of CFU-GM and the most sion.
11 While expansion with hematopoietic growth factors has been shown to increase the number of multipotent colefficient combination for expansion of CFU-GEMM. The addition of Epo or Epo and GM-CSF to the growth factor ony-forming cells, prolonged culture often resulted in an exhaustion of the most primitive progenitors.
14,15,23 Howcocktail increased the number of CFC, however the majority of cells consisted of more differentiated BFUever, during recent years several new aspects occurred, which might be helpful in solving this problem. The tyro-E/CFU-E and CFU-GM. In contrast, the number of CFU-GEMM fell. The analysis of the expansion kinetics revealed sine kinase receptor Flt3/Flk-2 ligand, Flt3-L was cloned 29 and synergistic effects with the c-kit ligand SCF, with ILthat a simultaneous amplification of the different progenitor types occurred within 7-14 days. Thus, the culture con-3 and with GM-CSF were described in the regulation of proliferation of both primitive multipotent and lineage comditions would fulfill a short-term criterion, important for clinical application. mitted hematopoietic progenitor cells. 30 More recently, several examples of culture systems that allow a net expansion
There have been a number of previous reports studying the effect of growth factor combinations on purified cell of bone marrow LTC-IC numbers have been reported by Koller et al 31 and Zandstra et al. 32 In addition, it has been expansion 17-22 but only a few included Flt3-L. 17, 19, 20 In addition, considerably less information is available on the shown that the majority of LTC-IC in marrow of normal adults might be quiescent, 33 although they are also able to question of stem cell maintenance/expansion during ex vivo expansion. Therefore, here Flt3-L, SCF and IL-3 in combiproliferate in response to stimulation by different factors in vitro. Moreover, as described by Ponchio et al, 33 the numnation with serum-containing or serum-free medium were in combination with H5100 medium or serum-free medium 269-270. resulted in the highest CFU-GM expansion within 7 days LTC-IC, respectively. However, the kinetics of the CFU-
